Preparation of monoclonal antibody 7H8 capable of resisting epitope at N terminal of human procalcitonin protein

A monoclonal antibody and protein technology, applied in the biological field, can solve the problems of high price and achieve the effect of improving specificity, ensuring integrity and reducing false positive rate
CN106399294AActive Publication Date: 2017-02-15HUNAN NORMAL UNIVERSITY
3 Cites 4 Cited by

Patent Information

Authority / Receiving Office
CN · China
Current Assignee / Owner
HUNAN NORMAL UNIVERSITY
Publication Date
2017-02-15

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention discloses a hybridoma cell capable of secreting monoclonal antibodies 7H8 capable of resisting amino acid sequences at the N terminal of human PCT (procalcitonin) protein. Through the prokaryotic expression of a human PCT whole-genome sequence with codon optimization in escherichia coli, the purified human PCT protein is taken as an antigen for immunizing BALB / c mice. Through cell fusion and screening, the hybridoma cell capable of stably secreting the monoclonal antibodies aiming at epitope at the N terminal of the human PCT protein is obtained, and the hybridoma cell is named as 7H8. The 7H8 monoclonal antibody can be used for testing PCT concentration of serum, and has high sensitivity and specificity. The 7H8 antibody identifies the amino acid sequences at the N terminal of the human PCT protein, the cross reaction with the calcitonin in the body is avoided, the specificity in identifying the PCT protein is improved, a very good novel material is provided for developing a diagnostic reagent corresponding to the PCT, and the technical scheme can be widely applied to the cytobiology and immunology experiments, and has a very good application value.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention belongs to the field of biotechnology and relates to a monoclonal antibody, in particular to a hybridoma cell secreting a monoclonal antibody against the N-terminal epitope of human PCT protein and the preparation of the specific monoclonal antibody. Background technique

[0002] Procalcitonin (PCT) is derived from the calcitonin I gene on human chromosome 11. After the gene is translated and expressed in thyroid C cells, it is converted by endogenous polypeptide enzyme The signal peptide of 25 amino acids at the N-terminus is cut off to form a 116 amino acid non-hormonally active calcitonin propeptide substance, namely procalcitonin (PCT). PCT consists of three parts: N-terminal (1-57aa)-calcitonin (60-91aa)-calcistatin (96-116aa), which are composed of 2 peptides (-Lys-Arg-) and 4 peptides (-Gly-Lys -Lys-Arg-) connection, the relative molecular mass is about 13 KDa, PCT is processed and hydrolyzed by a series of intracellular proteases...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More